Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8257153rdf:typepubmed:Citationlld:pubmed
pubmed-article:8257153lifeskim:mentionsumls-concept:C0027573lld:lifeskim
pubmed-article:8257153lifeskim:mentionsumls-concept:C0008809lld:lifeskim
pubmed-article:8257153lifeskim:mentionsumls-concept:C0028902lld:lifeskim
pubmed-article:8257153lifeskim:mentionsumls-concept:C0279516lld:lifeskim
pubmed-article:8257153lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:8257153lifeskim:mentionsumls-concept:C0370215lld:lifeskim
pubmed-article:8257153lifeskim:mentionsumls-concept:C0169734lld:lifeskim
pubmed-article:8257153pubmed:issue10lld:pubmed
pubmed-article:8257153pubmed:dateCreated1994-1-13lld:pubmed
pubmed-article:8257153pubmed:abstractTextOPC-17116 is a new fluoroquinolone with potent activity against aerobic and anaerobic organisms. We evaluated the susceptibilities of 200 clinical gonococcal isolates including organisms with plasmid and chromosomally mediated resistance to beta-lactams and tetracycline. The antibiotics studied included OPC-17116, ofloxacin, ciprofloxacin, penicillin, tetracycline, erythromycin, azithromycin, and ceftriaxone. All isolates tested were susceptible to the quinolone class of antibiotics. The MICs of ciprofloxacin, ofloxacin, and OPC-17116 for 90% of isolates tested were 0.004, 0.03, and 0.004 micrograms/ml, respectively. For organisms with chromosomally mediated resistance to penicillin and tetracycline, geometric mean MICs of all antibiotics including the quinolones were increased.lld:pubmed
pubmed-article:8257153pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:languageenglld:pubmed
pubmed-article:8257153pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:citationSubsetIMlld:pubmed
pubmed-article:8257153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8257153pubmed:statusMEDLINElld:pubmed
pubmed-article:8257153pubmed:monthOctlld:pubmed
pubmed-article:8257153pubmed:issn0066-4804lld:pubmed
pubmed-article:8257153pubmed:authorpubmed-author:NeumannTTlld:pubmed
pubmed-article:8257153pubmed:authorpubmed-author:PattonMMlld:pubmed
pubmed-article:8257153pubmed:authorpubmed-author:ZenilmanJ MJMlld:pubmed
pubmed-article:8257153pubmed:authorpubmed-author:ReichartCClld:pubmed
pubmed-article:8257153pubmed:issnTypePrintlld:pubmed
pubmed-article:8257153pubmed:volume37lld:pubmed
pubmed-article:8257153pubmed:ownerNLMlld:pubmed
pubmed-article:8257153pubmed:authorsCompleteYlld:pubmed
pubmed-article:8257153pubmed:pagination2244-6lld:pubmed
pubmed-article:8257153pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:meshHeadingpubmed-meshheading:8257153-...lld:pubmed
pubmed-article:8257153pubmed:year1993lld:pubmed
pubmed-article:8257153pubmed:articleTitleAntibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae.lld:pubmed
pubmed-article:8257153pubmed:affiliationDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.lld:pubmed
pubmed-article:8257153pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8257153pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8257153lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8257153lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8257153lld:pubmed